Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: December 2008
-
January 3-7, 2009 – 26th Annual National CLE Conference (Law Education Institute) – Vail, CO January 12-13, 2009 – Pharmaceutical and Biotech Patent Opinion Writing*** (American Conference Institute) – San Diego, CA January 20-21, 2009 – Bio/Pharmaceutical Summit on Legal and Regulatory Product Lifecycle Strategies*** (Center for Business Intelligence) – Baltimore, MD January 26-27, 2009…
-
By Donald Zuhn — On Thursday, the U.S. Patent and Trademark Office issued a reminder notice to all registered patent attorneys and agents to update their contact information via the Office's new online registration system. Patent Docs first reported on the new online registration system last summer. According to the Patent Office's notice, each…
-
American Conference Institute (ACI) will be holding its Pharmaceutical and Biotech Patent Claim Drafting conference on February 23-24 in Palo Alto, California. The course will be repeated on March 9-10, 2009 in Research Triangle Park, North Carolina and on March 30-31, 2009 in New York. The conference will provide hands-on training with respect to: •…
-
By Kevin E. Noonan — On December 3rd, the biotechnology, chemical, and pharmaceuticals (BCP) technology groups at the U.S. Patent and Trademark Office held their most recent quarterly customer partnership meeting. During one of six presentations, Kathleen Bragdon, a Quality Assurance Specialist from Technology Center 1600, presented "A Look at Personalized Medicine." In prior years,…
-
By Christopher P. Singer — In a memorandum dated December 10, 2008, the USPTO announced that, in response to comments from its customers, it has modified the requirements for requesting participation in the patent prosecution highway (PPH) pilot program. The changes will take effect on December 22, 2008, and will allow certain U.S. applications based on…
-
By Donald Zuhn — Yesterday, we reported on a Notice published by the U.S. Patent and Trademark Office in today's Federal Register announcing a delay in the effective date of the new rules relating to Practice before the Board of Patent Appeals and Interferences in Ex Parte Appeals (Appeals rules). Today, the Patent Office…
-
By Kevin E. Noonan — Roll Call, the Newspaper of Capitol Hill since 1955, announced today that Rep. Xavier Becerra (D-CA, 31st Dist.) "appears poised to accept a post as U.S. trade representative" in the Obama administration. We here at Patent Docs, and all reasoning members of the patent community, wish Rep. Becerra (at…
-
By Christopher P. Singer — In a Notice to be published in tomorrow's Federal Register, the U.S. Patent and Trademark Office announced that the new rules relating to Practice before the Board of Patent Appeals and Interferences in Ex Parte Appeals (Appeal rules) will not take effect on December 10, 2008, as originally scheduled.…
-
By Donald Zuhn — Last Friday, the Federal Circuit heard oral argument in the Tafas v. Dudas appeal. Arguing on behalf of Defendants-Appellants Director Jon Dudas and the U.S. Patent and Trademark Office was USPTO General Counsel James Toupin. Plaintiffs-Appellees SmithKline Beecham Corp., SmithKline Beecham plc, and Glaxo Group Ltd. (GSK) were represented by…
-
By Kevin E. Noonan — The Enlarged Board of the European Patent Office issued its decision denying a European patent on European Patent Application No. 96903521.1 (EP 0 770 125) to the Wisconsin Alumni Research Foundation (WARF), directed to human embryonic stem cells (hESCs). This decision is another example of European antipathy to biotechnology…
Patent Docs 